These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 1898838)

  • 1. Lupus anticoagulant inhibition of in vitro prostacyclin release is associated with a thrombosis-prone subset of patients.
    Watson KV; Schorer AE
    Am J Med; 1991 Jan; 90(1):47-53. PubMed ID: 1898838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lupus anticoagulant induces a selective defect in thrombin-mediated endothelial prostacyclin release and platelet aggregation.
    Schorer AE; Wickham NW; Watson KV
    Br J Haematol; 1989 Mar; 71(3):399-407. PubMed ID: 2495019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times.
    Alving BM; Barr CF; Tang DB
    Am J Med; 1990 Feb; 88(2):112-6. PubMed ID: 2105643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombosis associated with antiphospholipid antibodies cannot be explained by effects on endothelial and platelet prostanoid synthesis.
    Hasselaar P; Derksen RH; Blokzijl L; de Groot PG
    Thromb Haemost; 1988 Feb; 59(1):80-5. PubMed ID: 3129812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lupus anticoagulant: clinical significance in anticardiolipin positive patients with systemic lupus erythematosus.
    McHugh NJ; Moye DA; James IE; Sampson M; Maddison PJ
    Ann Rheum Dis; 1991 Aug; 50(8):548-52. PubMed ID: 1909518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of lupus anticoagulants: antiphospholipid antibodies, endothelium associated immunoglobulin, endothelial prostacyclin secretion, and antigenic protein S levels.
    Walker TS; Triplett DA; Javed N; Musgrave K
    Thromb Res; 1988 Aug; 51(3):267-81. PubMed ID: 2972088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphospholipid antibodies and thrombosis in systemic lupus erythematosus: comparison of three lupus anticoagulant assays and anticardiolipin ELISA in 188 patients.
    Jouhikainen T; Julkunen H; Vaarala O; Leirisalo-Repo M; Stephansson E; Vahtera E; Palosuo T; Myllylä G
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):407-14. PubMed ID: 1420816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial prostacyclin release in systemic lupus erythematosus.
    Coade SB; van Haaren E; Loizou S; Walport MJ; Denman AM; Pearson JD
    Thromb Haemost; 1989 Feb; 61(1):97-100. PubMed ID: 2665169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid antibodies: a disease marker in 25 patients with antinuclear antibody negative systemic lupus erythematosus (SLE). Comparison with a group of 91 patients with antinuclear antibody positive SLE.
    Meyer O; Piette JC; Bourgeois P; Fallas P; Bletry O; Jungers P; Kahn MF; Godeau P; Ryckewaert A
    J Rheumatol; 1987 Jun; 14(3):502-6. PubMed ID: 3114485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.
    Love PE; Santoro SA
    Ann Intern Med; 1990 May; 112(9):682-98. PubMed ID: 2110431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lupus anticoagulant, anticardiolipin antibody or antiphospholipid syndrome?
    Malaviya AN
    J Assoc Physicians India; 1991 Mar; 39(3):239-41. PubMed ID: 1908856
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiphospholipid antibodies: an elderly statesman Dons new garments.
    Harris EN; Hughes GR; Gharavi AE
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():208-13. PubMed ID: 3112376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 'antiphospholipid syndrome' and the 'lupus anticoagulant'.
    Cameron JS; Frampton G
    Pediatr Nephrol; 1990 Nov; 4(6):663-78. PubMed ID: 2128460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome.
    Asherson RA; Khamashta MA; Gil A; Vazquez JJ; Chan O; Baguley E; Hughes GR
    Am J Med; 1989 Apr; 86(4):391-9. PubMed ID: 2494884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiphospholipid antibodies: specificity and mechanism of action].
    Tobelem G
    Ann Med Interne (Paris); 1990; 141(3):257-60. PubMed ID: 2114812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet autoantibodies detected by immunoblotting in systemic lupus erythematosus: association with the lupus anticoagulant, and with history of thrombosis and thrombocytopenia.
    Jouhikainen T; Kekomäki R; Leirisalo-Repo M; Bäcklund T; Myllylä G
    Eur J Haematol; 1990 Apr; 44(4):234-9. PubMed ID: 2111779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients.
    Derksen RH; Hasselaar P; Blokzijl L; Gmelig Meyling FH; De Groot PG
    Ann Rheum Dis; 1988 May; 47(5):364-71. PubMed ID: 3133992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid antibodies--autoantibodies with a difference.
    Harris EN; Asherson RA; Hughes GR
    Annu Rev Med; 1988; 39():261-71. PubMed ID: 3130772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding specificity of lupus anticoagulants and anticardiolipin antibodies.
    McNeil HP; Chesterman CN; Krilis SA
    Thromb Res; 1988 Dec; 52(6):609-19. PubMed ID: 3148207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for thrombosis in lupus patients.
    Hasselaar P; Derksen RH; Blokzijl L; Hessing M; Nieuwenhuis HK; Bouma BN; De Groot PG
    Ann Rheum Dis; 1989 Nov; 48(11):933-40. PubMed ID: 2512863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.